Th22 Cells Contribution in Immunopathogenesis of Rheumatic Diseases
Abstract
Newly identified T helper cell 22 (Th22) is a subset of CD4+T cells with specific properties apart from other known CD4+ T cell subsets with distinguished gene expression and function. Th22 cells are characterized by production of a distinct profile of effector cytokines, including interleukin (IL)-22, IL-13, and tumor necrosis factor-α (TNF-α). The levels of Th22 and related cytokine IL-22 are increased in various autoimmune diseases and positively associated with some rheumatic diseases such as rheumatoid arthritis, systemic lupus erythematosus, behcet's disease, ankylosing spondylitis and psoriatic arthritis. In summary, IL-22 and Th22 cells play a significant and complicated role in inflammatory and autoimmune rheumatic diseases, therefore, targeting IL-22 or Th22 have unique and attractive advantages due to the fact that Th22 subset is recently identified and its associated research is extremely limited. This review discusses the role of Th22 and its cytokine IL-22 in the immunopathogenesis of rheumatic disease.
1. Radenska-Lopovok SG. [Cell and cytokine markers in the synovial membrane in rheumatoid arthritis]. Arkh Patol 2013; 75(5):58-62.
2. Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 2007; 117(5):1119-27.
3. Li H, Rostami A. IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity. J Neuroimmune Pharmacol 2010; 5(2):198-209.
4. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ Tcell lineage differentiation. Immunity 2009; 30(5):646-55.
5. Nakayamada S, Takahashi H, Kanno Y, O'Shea JJ.Helper T cell diversity and plasticity. Curr Opin Immunol 2012; 24(3):297-302.
6. Larsen M, Arnaud L, Hie M, Parizot C, Dorgham K, Shoukry M, et al. Multiparameter grouping delineates heterogeneous populations of human IL-17 and/or IL-22 T-cell producers that share antigen specificities with other T-cell subsets. Eur J Immunol 2011;41(9):2596-605.
7. Lexberg MH, Taubner A, Albrecht I, Lepenies I, Richter A, Kamradt T, et al. IFN-gamma and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells. Eur J Immunol 2010; 40(11):3017-27.
8. Kurschus FC, Croxford AL, Heinen AP, Wortge S, Ielo D, Waisman A. Genetic proof for the transient nature of the Th17 phenotype. Eur J Immunol 2010; 40(12):3336-46.
9. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, Elson CO, et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009; 30(1):92-107.
10. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009;119(12):3573-85.
11. Shen W, Li W, Feigenbaum L, Hixon J, Durum S.Plasticity in the differentiation of IL-22 producing cells. The Journal of Immunology. 2013;190, (Meeting Abstract Supplement) 193.2.
12. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H.Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 2009;10(8):864-71.
13. Truchetet ME, Brembilla NC, Montanari E, Allanore Y, Chizzolini C. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther 2011; 13(5):R166.
14. Cheng RH. [Expression level of Th22 cells and its cytokines in patients with acute lymphoblastic leukemia and its significance]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2013; 21(4):857-60.
15. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009; 10(8):857-63.
16. Baba N, Rubio M, Kenins L, Regairaz C, Woisetschlager M, Carballido JM, et al. The aryl hydrocarbon receptor (AhR) ligand VAF347 selectively acts on monocytes and naive CD4(+) Th cells to promote the development of IL-22-secreting Th cells. Hum Immunol 2012 Aug;73(8):795-800.
17. Alam MS, Maekawa Y, Kitamura A, Tanigaki K, Yoshimoto T, Kishihara K, et al. Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 2010;107(13):5943-8.
18. Ramirez JM, Brembilla NC, Sorg O, Chicheportiche R, Matthes T, Dayer JM, et al. Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur J Immunol 2010; 40(9):2450-9.
19. Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, Krueger JG. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci U S A 2009; 106(51):21795-800.
20. Duluc D, Gannevat J, Anguiano E, Zurawski S, Carley M, Boreham M, et al. Functional diversity of human vaginal APC subsets in directing T-cell responses. Mucosal Immunol 2013; 6(3):626-38.
21. Dumoutier L, Van Roost E, Ameye G, Michaux L, Renauld JC. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun 2000; 1(8):488-94.
22. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, et al. Surface phenotype and antigenic specificity of human interleukin 17- producing T helper memory cells. Nat Immunol 2007;8(6):639-46.
23. Volpe E, Touzot M, Servant N, Marloie-Provost MA, Hupe P, Barillot E, et al. Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production. Blood 2009; 114(17):3610-4.
24. Nograles KE, Zaba LC, Shemer A, Fuentes-Duculan J, Cardinale I, Kikuchi T, et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009; 123(6):1244-52.
25. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009; 457(7230):722-5.
26. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov, II, et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009;206(1):35-41.
27. Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 2005; 174(6):3695-702.
28. Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000; 275(40):31335-9.
29. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004; 21(2):241-54.
30. Zenewicz LA, Flavell RA. Recent advances in IL-22 biology. Int Immunol 2011; 23(3):159-63.
31. Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 2002; 277(37):33676-82.
32. Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunol Rev 2013; 252(1):116-32.
33. Zhang L, Li YG, Li YH, Qi L, Liu XG, Yuan CZ, et al.Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PloS one 2012;7(4):e31000.
34. Yang XY, Wang HY, Zhao XY, Wang LJ, Lv QH, Wang QQ. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus. J Clin Immunol 2013; 33(4):767-74.
35. Sugita S, Kawazoe Y, Imai A, Kawaguchi T, Horie S, Keino H, et al. Role of IL-22- and TNF-alpha-producing Th22 cells in uveitis patients with Behcet's disease. J Immunol 2013; 190(11):5799-808.
36. Benham H, Norris P, Goodall J, Wechalekar MD, FitzGerald O, Szentpetery A, et al. Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Res Ther 2013; 15(5):R136.
37. Azizi G, Jadidi-Niaragh F, Mirshafiey A. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis. Int J Rheum Dis 2013; 16(3):243-53.
38. Muller-Ladner U, Pap T, Gay RE, Neidhart M, Gay S.Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol 2005; 1(2):102-10.
39. Zhang L, Li JM, Liu XG, Ma DX, Hu NW, Li YG, et al.Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol 2011;31(4):606-14.
40. van Hamburg JP, Corneth OB, Paulissen SM, Davelaar N, Asmawidjaja PS, Mus AM, et al. IL-17/Th17 mediated synovial inflammation is IL-22 independent. Ann Rheum Dis 2013; 72(10):1700-7.
41. Zhao L, Jiang Z, Jiang Y, Ma N, Zhang Y, Feng L, et al.IL-22+ CD4+ T cells in patients with rheumatoid arthritis. Int J Rheum Dis 2013; 16(5):518-26.
42. Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, Ueki K, et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 2005;52(4):1037-46.
43. da Rocha LF, Jr., Duarte AL, Dantas AT, Mariz HA, Pitta Ida R, Galdino SL, et al. Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity. J Rheumatol 2012; 39(7):1320-5.
44. Kiriakidou M, Cotton D, Taichman D, Williams S.Systemic lupus erythematosus. Ann Intern Med 2013;159(7):ITC4-1.
45. Abou Ghanima AT, Elolemy GG, Ganeb SS, Abo Elazem AA, Abdelgawad ER. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus. Egypt J Immunol 2012; 19(2):25-33. PubMed PMID: 23885404.
46. Zhao L, Jiang Z, Jiang Y, Ma N, Wang K, Zhang Y, et al.IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus. Exp Biol Med (Maywood) 2013;238(2):193-9.
47. Cheng F, Guo Z, Xu H, Yan D, Li Q. Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 2009; 68(4):604-6.
48. Lin J, Yue LH, Chen WQ. Decreased Plasma IL-22 Levels and Correlations with IL-22-Producing T Helper Cells in Patients with New-Onset Systemic Lupus Erythematosus. Scand J Immunol 2014; 79(2):131-6.
49. Paramarta JE, Baeten D. Spondyloarthritis: from unifying concepts to improved treatment. Rheumatology 2013.
50. Chou CT. How to translate basic knowledge into clinical application of biologic therapy in spondyloarthritis. Clin Dev Immunol 2013; 2013:369202.
51. Romero-Sanchez C, Jaimes DA, Londono J, De Avila J, Castellanos JE, Bello JM, et al. Association between Th-17 cytokine profile and clinical features in patients with spondyloarthritis. Clin Exp Rheumatol 2011; 29(5):828-34.
52. Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009; 60(6):1647-56.
53. Ciccia F, Accardo-Palumbo A, Alessandro R, Rizzo A, Principe S, Peralta S, et al. Interleukin-22 and interleukin-
22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Arthritis Rheum 2012; 64(6):1869-78.
54. Balakrishnan C, Madnani N. Diagnosis and management of psoriatic arthritis. Indian J Dermatol Venereol Leprol 2013; 79 (Suppl 7):S18-24.
55. Mitra A, Raychaudhuri SK, Raychaudhuri SP. Functional role of IL-22 in psoriatic arthritis. Arthritis Res Ther 2012; 14(2):R65.
56. Houman MH, Bel Feki N. [Pathophysiology of Behcet's disease]. Rev Med Interne 2014; 35(2):90-6.
57. Aktas Cetin E, Cosan F, Cefle A, Deniz G. IL-22- secreting Th22 and IFN-gamma-secreting Th17 cells in Behcet's disease. Mod Rheumatol 2014.
58. Cai T, Wang Q, Zhou Q, Wang C, Hou S, Qi J, et al.Increased expression of IL-22 is associated with disease activity in Behcet's disease. PloS one 2013; 8(3):e59009.
59. Na SY, Park MJ, Park S, Lee ES. Up-regulation of Th17 and related cytokines in Behcet's disease corresponding to disease activity. Clin Exp Rheumatol 2013; 31(3 Suppl 77):32-40.
60. Usui Y. [Expression and function of ICOS on CD4 T cells and application to therapy in patients with ocular Behcet's disease with uveitis]. Nihon Ganka Gakkai Zasshi 2012; 116(11):1037-45.
61. Carrion M, Juarranz Y, Martinez C, Gonzalez-Alvaro I, Pablos JL, Gutierrez-Canas I, et al. IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts. Rheumatology 2013; 52(12):2177-86.
| Files | ||
| Issue | Vol 14, No 3 (2015) | |
| Section | Review Article(s) | |
| Keywords | ||
| IL-22 Rheumatic disease Rheumatoid arthritis Systemic lupus erythematosus Th22 | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
